Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Santora

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
The American Journal of Medicine|November 1, 1996
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosisJ R Tucci, R P Tonino, R D Emkey, et al.
BMC Musculoskeletal Disorders|November 8, 2018
Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in ThailandThawee Songpatanasilp, Sattaya Rojanasthien, Pansak Sugkraroek, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 19, 2021
Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysisK Saag, F Cosman, T De Villiers, et al.
Radiology|July 1, 1984
Parathyroid aspiration directed by angiography: an alternative to venous samplingA G Krudy, J L Doppman, S J Marx, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 30, 2013
Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis--a double-blind, randomized, dose-finding studyT Nakamura, M Shiraki, M Fukunaga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 14, 2005
Osteoporosis and fracture risk in women of different ethnic groupsElizabeth Barrett-Connor, Ethel S Siris, Lois E Wehren, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 4, 2011
Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trialsE Barrett-Connor, A S Swern, C M Hustad, et al.
Journal of the American Geriatrics Society|March 25, 2000
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research GroupK E Ensrud, D E Thompson, J A Cauley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 5, 2024
Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 studyLiana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, et al.
Menopause (New York, N.Y.)|September 23, 2003
Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) studyElizabeth Barrett-Connor, Lois E Wehren, Ethel S Siris, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
The American Journal of Medicine|November 1, 1996
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosisJ R Tucci, R P Tonino, R D Emkey, et al.
BMC Musculoskeletal Disorders|November 8, 2018
Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in ThailandThawee Songpatanasilp, Sattaya Rojanasthien, Pansak Sugkraroek, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 19, 2021
Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysisK Saag, F Cosman, T De Villiers, et al.
Radiology|July 1, 1984
Parathyroid aspiration directed by angiography: an alternative to venous samplingA G Krudy, J L Doppman, S J Marx, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 30, 2013
Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis--a double-blind, randomized, dose-finding studyT Nakamura, M Shiraki, M Fukunaga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 14, 2005
Osteoporosis and fracture risk in women of different ethnic groupsElizabeth Barrett-Connor, Ethel S Siris, Lois E Wehren, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 4, 2011
Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trialsE Barrett-Connor, A S Swern, C M Hustad, et al.
Journal of the American Geriatrics Society|March 25, 2000
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research GroupK E Ensrud, D E Thompson, J A Cauley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 5, 2024
Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 studyLiana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, et al.
Menopause (New York, N.Y.)|September 23, 2003
Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) studyElizabeth Barrett-Connor, Lois E Wehren, Ethel S Siris, et al.
Pageof 7